Successful Thrombolysis of Acute Left Atrial Thrombi in Two Pediatric Patients Following Interventional Cardiac Catheterization

Journal of Invasive Cardiology

Volumn 16, Issue 1, 2004, Pages 35-39

  Herron, Sandra B ^a   Lax, Daniela ^a   Zamora, Rolando ^a,b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ARTICLE; BLEEDING; BLOOD CLOT LYSIS; CASE REPORT; CEREBROVASCULAR ACCIDENT; CHILD; ECHOCARDIOGRAPHY; EMBOLISM; EPISTAXIS; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM THROMBOSIS; HEART CATHETERIZATION; HEMATEMESIS; HEMOPERICARDIUM; HUMAN; MALE;

ABNORMALITIES, MULTIPLE; CHILD; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HEART DEFECTS, CONGENITAL; HEART DISEASES; HUMANS; MALE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; THROMBOLYTIC THERAPY; THROMBOSIS; TREATMENT OUTCOME;

EID: 0346492574     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Vitiello R, McCrindle BW, Nykanen D, et al. Complications associated with pediatric cardiac catheterization. J Am Coll Cardiol 1998;32:1433-1440.
2. Levy M, Benson LN, Burrows PS. Tissue plasminogen activator for the treatment of thromboembolism in infants and children. J Pediatr 1991;118:467-472.
3. Zalzstein E, Zucker N, Levitas A. The role of tissue plasminogen activator in the successful treatment of infected cardiac thrombus in children. Cardiol Young 2001;11:355-356.
4. Knofler R, Dinger J, Kabus M, et al. Thrombolytic therapy in children - Clinical experience with recombinant tissue-plasminogen activator. Semin Thromb Hemost 2001;27:169-174.
5. La Rosee K, Deutsch HJ, Schnabel P. Thrombus formation after transcatheter closure of atrial septal defect. Am J Cardiol 1999;84:356-359.
6. Gastmann O, Werner GS, Babic UU. Thrombus formation on transcatheter ASD occluder device in a patient with coagulation factor XII deficiency. Cathet Cardiovasc Diagn 1998;43:81-83.
7. Franke A, Kuhl HP, Muehler EG. Transcatheter closure of atrial septal defects after paradoxical embolism: Frequency of occluder-related atrial thrombi despite prophylactic therapy. Circulation 2000;102:SII-588.
8. Kehl HG, Kececioglu D, Vielhaber H. Left atrial thrombus in a 10-month-old boy - Successful thrombolysis with recombinant tissue-type plasminogen activator after open-heart surgery: Review of the literature. Intens Care Med 1996;22:968-971.
9. Martinez-Tallo E, Campo F, Delgado M. Thrombus in right atrium in two infants successfully treated with tissue plasminogen activator. Pediatr Emer Care 1997;13:37-39.
10. ACC/AHA/ESC Guidelines for the Management of Patients with Atrial Fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences. J Am Coll Cardiol 2001;38:1266i-lxx.
11. Kothari SS, Varma S, Wasir HS. Thrombolytic therapy in infants and children. Am Heart J 1994;127:651-657.
12. Pyles LA, Pierpont MEM, Steiner ME. Fibrinolysis by tissue plasminogen activator in a child with pulmonary embolism. J Pediatr 1990;116:801-804.
13. Zenz W, Muntean W, Beitzke A. Tissue plasminogen activator (alteplase) treatment for femoral artery thrombosis after cardiac catheterisation in infants and children. Br Heart J 1993;70:382-385.
14. Beitzke A, Zobel G, Zenz W. Catheter-directed thrombolysis with tissue plasminogen activator for acute pulmonary embolism after Fontan operation. Pediatr Cardiol 1996;17:410-412.
15. Horigome H, Sekifima T, Miyamoto T. Successful thrombolysis with intracoronary administration of tissue plasminogen activator in an infant with Kawasaki's disease. Heart 1997;78:517-518.
16. Reid CJD, Segal T. Pulmonary thrombo-embolism in nephrotic syndrome treated with tissue plasminogen activator. Eur J Pediatr 1197;156:647-649.
17. Corrigan JJ. Hemostasis. In: Hemorrhagic and Thrombotic Diseases in Childhood and Adolescence. New York: Churchill Livingstone, 1985: pp. 10-11.
18. Male C, Lechner K, Eichinger S. Clinical significance of lupus anticoagulants in children. J Pediatr 1999;134:199-205.
19. Young G, Krohn K, Packer R. Prothrombin G20210A mutation in a child with spinal cord infarction. J Pediatr 1999;134:777-779.
20. Streif W, Andrew M. Venous thromboembolic events in pediatric patients: Diagnosis and management. J Pediatr 1998;12:1283-1312.
21. Lambert V, Losay J, Piot JD. Late complications of percutaneous closure of atrial septal defects with the Sideris occluder. Arch Mal Coeur Vaiss 1997;90:245-251.